Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2011 Jul;17(7):615-8.

[Tamoxifen combined with coenzyme Q10 for idiopathic oligoasthenospermia]

[Article in Chinese]
Kai-Fa Tang  1 , Yao Xing, Chun-Yun Wu, Rui-Zhe Liu, Xin-Yang Wang, Jun-Ping Xing
Affiliations
  • PMID: 21823344
Randomized Controlled Trial

[Tamoxifen combined with coenzyme Q10 for idiopathic oligoasthenospermia]

[Article in Chinese]
Kai-Fa Tang et al. Zhonghua Nan Ke Xue. 2011 Jul.

Abstract

Objective: To investigate the effects of tamoxifen (TMX) combined with coenzyme Q10 (CoQ10) on idiopathic oligoasthenospermia.

Methods: A total of 183 patients with idiopathic oligoasthenospermia were randomly divided into a TMX + CoQ10 group (n = 63), a TMX group (n = 61) and a CoQ10 group (n = 59). At the end of 3 and 6 months of treatment, semen analyses and hormone tests were performed, and the results were compared with those obtained before the treatment.

Results: Compared with the pre-treatment results, the levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH) and testosterone (T) and sperm concentration were significantly elevated in the TMX + CoQ10 and TMX groups (P < 0.05), but showed no significant difference in the CoQ10 group (P > 0.05); sperm motility and morphologically normal sperm were increased significantly in the TMX + CoQ10 and CoQ10 groups (P < 0.05), and slightly in the TMX group but with no statistically significant difference (P > 0.05).

Conclusion: Tamoxifen combined with CoQ10 can significantly improve sperm concentration, motility and morphology in patients with idiopathic oligoasthenospermia.

PubMed Disclaimer

Publication types